AstraZeneca’s Covishield causes rare blood clot-disorder TTS, admits Covid vaccine’s side effect

In a legal document submitted before the High Court of Justice, London, UK pharmaceutical giant AstraZeneca has admitted that its Covid vaccine, Covishield, ‘can, in very rare cases, cause TTS’ – Thrombosis with Thrombocytopenia Syndrome, a clotting disorder